Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.
View all
Cytovia Therapeutics
New York, United States
Ublo
Paris, France
VantAI
New York, United States
HiberCell
New York, United States
73 Strings
Paris, France
Kard
Paris, France
The Ring
Lille, France
Blank
Paris, France
AKUR8
Paris, France
betoobe
Saint-rémy-de-provence, France
Scenic Biotech
Amsterdam, Netherlands
Flow Robotics
Copenhagen, Denmark